Aclarion
-
Spine
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent…
Read More » -
Spine
Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor
Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion…
Read More » -
Spine
Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium
NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support…
Read More » -
Spine
Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Director of Endoscopic Spine Surgery at the University of Miami Broomfield, CO, Jan. 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion”…
Read More » -
Spine
Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor
Broomfield, CO, Jan. 17, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company…
Read More » -
Spine
Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is…
Read More »